跳至主要内容
临床试验/CTRI/2015/11/006333
CTRI/2015/11/006333尚未招募2 期

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE ROLE OF DIET THERAPY AND VYOSHADI SAKTU IN OBESITY

Government Ayurveda Medical college Mysore1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2015年11月27日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Decrease in body weight and body mass index

研究概览

简要总结

This study is a randomized, parallel group, single-centre  trail comparing the efficacy of diet therapy and Vyoshadi saktu for 30 days in 60 patients with obesity that will be conducted in Govt. ayurveda Medical college, Mysore in India, The primary outcome measures will be Decrease in body weight and body mass index, Decrease in waist circumference and waist hip ratio (anthropometric measurements). The secondary outcomes will Decrease in cholesterol, Triglycerides, LDL and VLDL values from baseline Increase in HDL values from baseline Increase in the levels of serum calcium and BMD

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • •Elevated levels of lipid profile •BMI between >30 to 40kg/m2 •Willing to come for regular follow-up visits •Able to give written information consent.

排除标准

  • •Intake of over the counter weight loss agents, centrally acting appetite suppressants in the previous six months •Pathophysiological/ genetic syndromes associated with obesity (Cushing’s syndrome, Turner’s syndrome, Prader willi syndrome) •Patients with evidence of malignancy •Patients with poorly controlled Diabetes Mellitus (HbA1c> 10%) •Patients with poorly controlled Hypertension (>160/100 mm Hg) •Patients on prolonged (> 6 weeks) medication with corticosteroids, antidepressants, anticholinergics, etc.
  • or any other drugs that may have an influence on the outcome of the study •Patients suffering from major systemic illness necessitating long term drug treatment (Rheumatoid arthritis, Tuberculosis, Psycho-Neuro-Endocrinal disorders etc.) •Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infraction, Stroke or Severe Arrhythmia in the last 6 months •Symptomatic patient with clinical evidence of Heart failure.
  • •Patients with concurrent serious hepatic disorder (defined as Aspartate Amino Transferase (AST) and / or Alanine Amino Transferase (ALT), Total Bilirubin, Alkaline Phosphatase (ALP) > 2.5 times upper normal limit) or Renal Disorders (defined as S.Creatinine > 1.2mg/dL), Severe Pulmonary Dysfunction (uncontrolled Bronchial Asthma and / or Chronic Obstructive Pulmonary Disease (COPD), or any other condition that may jeopardize the study.
  • •History of HIV and other viral infections •Alcoholics and/or drug abusers •Prior surgical therapy for obesity •History of hypersensitivity to any of the herbal extracts or dietary supplements.
  • •Pregnant/ lactating women.
  • •Patients who have completed participation in any other clinical trial during the past six (03) months.
  • •Any other condition which the principal investigator thinks may jeopardize the study.

结局指标

主要结局

Decrease in body weight and body mass index

时间窗: 30 days

Decrease in waist circumference and waist hip ratio (anthropometric measurements)

时间窗: 30 days

次要结局

  • Decrease in cholesterol, Triglycerides, LDL and VLDL values from baseline(Increase in HDL values from baseline)

研究者

发起方
Government Ayurveda Medical college Mysore
申办方类型
Research institution

研究点 (1)

Loading locations...

相似试验

EFFECT OF DIET THERAPY AND VYOSHADI SAKTU IN... | 临床试验